1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Venous Thromboembolic Disease: new trials by email Literature Review of Venous Thromboembolic Disease trials Research Report on Venous Thromboembolic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study treatment "intervention", treatment "standard", biological assessment - Prolonged Anticoagulation, Venous Thromboembolic Disease | Phase 2 | Recruiting | Centre Hospitalier Universitaire Dijon | 72 | 2022-02-03 | 2025-12-22 |
| Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation ATI-5923, Coumadin (warfarin) - Atrial Fibrillation, Atrial Flutter | Phase 2 / Phase 3 | Unknown | ARYx Therapeutics | 600 | 2008-05-01 | 2010-02-02 |
Anemia, Hemolytic, Autoimmune (1) · Atrial Fibrillation (1) · Atrial Flutter (1) · Cardiomyopathies (1) · Myocardial Infarction (1)
Anemia (1) · Anemia, Hemolytic (1) · Arrhythmias, Cardiac (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Heart Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Infarction (1) · Ischemia (1) · Myocardial Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Crisis Intervention (1) · Warfarin (1) · tecarfarin (1)
ARYx Therapeutics (1) · Centre Hospitalier Universitaire Dijon (1)
France (1) · United States (1)